INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS:SHORT-TERM AND ONE YEAR OUTCOME OF THREE DOSE REGIMEN. AN ITALIAN MULTICENTRE OPEN-LABEL STUDY

(1) Gastroenterology, A.O.S.Camillo Forlanini

(2) Terapia Medica C I C, Univ Cattolica

(3) Gastroenterology, S.Filippo Neri, Roma

(4) Gastroenterology, ASO Ordine Mauriziano, Torino

(5) Gastroenterology, Univ Tor Vergata, Roma

(6) Gastroenterology, Univ of Palermo, Palermo

(7) Gastroenterology, ASO S.Croce e Carle, Cuneo

(8) Gastroenterology, IRCCS Casa Sollievo della Sofferenza, S.Giovanni Rotondo

(9) Internal Medicine, Ospedale Cervello, Palermo

(10) Gastroenterology, Univ La Sapienza, Roma

(11) Gastroenterology, II Univ Napoli, Napoli

(12) Gastroenterology, A.O. Valduce, Como, Italy



This item was part of the IMMFLAMMATORY BOWEL DISEASE II session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A325